-
1
-
-
0023698530
-
Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture
-
Hill SM, Blask DE,. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988; 48: 6121-6126.
-
(1988)
Cancer Res
, vol.48
, pp. 6121-6126
-
-
Hill, S.M.1
Blask, D.E.2
-
3
-
-
0036479749
-
Melatonin as a chronobiotic/anticancer agent: Cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy
-
Blask DE, Sauer LA, Dauchy RT,. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2002; 2: 113-132.
-
(2002)
Curr Top Med Chem
, vol.2
, pp. 113-132
-
-
Blask, D.E.1
Sauer, L.A.2
Dauchy, R.T.3
-
5
-
-
33646787132
-
Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions
-
Cos S, González A, Martínez-Campa C, et al. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 2006; 30: 118-128.
-
(2006)
Cancer Detect Prev
, vol.30
, pp. 118-128
-
-
Cos, S.1
González, A.2
Martínez-Campa, C.3
-
7
-
-
47249134191
-
Selective estrogen enzyme modulator (SEEM) actions of melatonin in human breast cancer cells
-
González A, Cos S, Martinez-Campa C, et al. Selective estrogen enzyme modulator (SEEM) actions of melatonin in human breast cancer cells. J Pineal Res 2008; 45: 86-92.
-
(2008)
J Pineal Res
, vol.45
, pp. 86-92
-
-
González, A.1
Cos, S.2
Martinez-Campa, C.3
-
8
-
-
84876326730
-
Melatonin and breast cancer: Selective estrogen enzyme modulator
-
Rahman A.U. ed., Bentham Science Publishers, Sharjah, UAE
-
Cos S, González A, Álvarez-García V, et al. Melatonin and breast cancer: selective estrogen enzyme modulator. In: Advances in Cancer Drug Targets, Vol 1., Rahman AU, ed., Bentham Science Publishers, Sharjah, UAE, 2012; pp. 207-237.
-
(2012)
Advances in Cancer Drug Targets
, vol.1
, pp. 207-237
-
-
Cos, S.1
González, A.2
Álvarez-García, V.3
-
9
-
-
14344253781
-
Melatonin modulates aromatase activity in MCF-7 human breast cancer cells
-
Cos S, Martínez-Campa C, Mediavilla MD, et al. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 2005; 38: 136-142.
-
(2005)
J Pineal Res
, vol.38
, pp. 136-142
-
-
Cos, S.1
Martínez-Campa, C.2
Mediavilla, M.D.3
-
10
-
-
28844438249
-
Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity
-
Cos S, González A, Güezmes A, et al. Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 2006; 118: 274-278.
-
(2006)
Int J Cancer
, vol.118
, pp. 274-278
-
-
Cos, S.1
González, A.2
Güezmes, A.3
-
11
-
-
84882997683
-
Optimal combination of radiotherapy and endocrine drugs in breast cancer treatment
-
Zeng ZJ, Li JH, Zhang YJ, et al. Optimal combination of radiotherapy and endocrine drugs in breast cancer treatment. Cancer Radiother 2013; 17: 208-214.
-
(2013)
Cancer Radiother
, vol.17
, pp. 208-214
-
-
Zeng, Z.J.1
Li, J.H.2
Zhang, Y.J.3
-
12
-
-
3042523093
-
Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: State of the art
-
Azria D, Lemanski C, Zouhair A, et al. Adjuvant treatment of breast cancer by concomitant hormonotherapy and radiotherapy: state of the art. Cancer Radiother 2004; 8: 188-196.
-
(2004)
Cancer Radiother
, vol.8
, pp. 188-196
-
-
Azria, D.1
Lemanski, C.2
Zouhair, A.3
-
13
-
-
57749187910
-
Concurrent hormone and radiation therapy in patients with breast cancer: What is the rationale?
-
Chargari C, Toillon RA, Macdermed D, et al. Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale? Lancet Oncol 2009; 10: 53-60.
-
(2009)
Lancet Oncol
, vol.10
, pp. 53-60
-
-
Chargari, C.1
Toillon, R.A.2
Macdermed, D.3
-
15
-
-
84882756472
-
Aromatase inhibition 2013: Clinical state of the art and questions that remain to be solved
-
Lonning PE, Eikesdal HP,. Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved. Endocr Relat Cancer 2013; 20: 183-201.
-
(2013)
Endocr Relat Cancer
, vol.20
, pp. 183-201
-
-
Lonning, P.E.1
Eikesdal, H.P.2
-
16
-
-
33644831920
-
Letrozole sensitizes breast cancer cells to ionizing radiation
-
Azria D, Larbouret C, Cunat S, et al. Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Res 2005; 7: R156-R163.
-
(2005)
Breast Cancer Res
, vol.7
, pp. R156-R163
-
-
Azria, D.1
Larbouret, C.2
Cunat, S.3
-
17
-
-
84873456547
-
Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells
-
Wang J, Yang Q, Haffty BG, et al. Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells. Biochem Biophys Res Commun 2013; 431: 146-151.
-
(2013)
Biochem Biophys Res Commun
, vol.431
, pp. 146-151
-
-
Wang, J.1
Yang, Q.2
Haffty, B.G.3
-
18
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
19
-
-
78650672113
-
Basic mechanisms involved in the anticancer effects of melatonin
-
Mediavilla MD, Sánchez-Barcelõ EJ, Tan DX, et al. Basic mechanisms involved in the anticancer effects of melatonin. Curr Med Chem 2010; 17: 4462-4481.
-
(2010)
Curr Med Chem
, vol.17
, pp. 4462-4481
-
-
Mediavilla, M.D.1
Sánchez-Barcelõ, E.J.2
Tan, D.X.3
-
20
-
-
0034983585
-
Anticarcinogenic actions of melatonin which involve antioxidative processes: Comparison with other antioxidants
-
Karbownik M, Lewinski A, Reiter RJ,. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int J Biochem Cell Biol 2001; 33: 735-753.
-
(2001)
Int J Biochem Cell Biol
, vol.33
, pp. 735-753
-
-
Karbownik, M.1
Lewinski, A.2
Reiter, R.J.3
-
21
-
-
0036161980
-
Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells
-
Kiefer T, Ram PT, Yuan L, et al. Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 2002; 71: 37-45.
-
(2002)
Breast Cancer Res Treat
, vol.71
, pp. 37-45
-
-
Kiefer, T.1
Ram, P.T.2
Yuan, L.3
-
22
-
-
0025828360
-
Effects of melatonin on the cell cycle kinetics and "estrogen rescue" of MCF-7 human breast cancer cells in culture
-
Cos S, Blask DE, Lemus-Wilson A, et al. Effects of melatonin on the cell cycle kinetics and "estrogen rescue" of MCF-7 human breast cancer cells in culture. J Pineal Res 1991; 10: 36-42.
-
(1991)
J Pineal Res
, vol.10
, pp. 36-42
-
-
Cos, S.1
Blask, D.E.2
Lemus-Wilson, A.3
-
23
-
-
0042913095
-
Melatonin inhibits telomerase activity in the MCF-7 tumor cell line in vivo and in vitro
-
Leon-Blanco M, Guerrero JM, Reiter RJ, et al. Melatonin inhibits telomerase activity in the MCF-7 tumor cell line in vivo and in vitro. J Pineal Res 2003; 35: 204-211.
-
(2003)
J Pineal Res
, vol.35
, pp. 204-211
-
-
Leon-Blanco, M.1
Guerrero, J.M.2
Reiter, R.J.3
-
24
-
-
0032188888
-
Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells
-
Cos S, Fernández R, Güezmes A, et al. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998; 58: 4383-4390.
-
(1998)
Cancer Res
, vol.58
, pp. 4383-4390
-
-
Cos, S.1
Fernández, R.2
Güezmes, A.3
-
25
-
-
28244481148
-
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of breast cancer xenografts in nude rats
-
Blask DE, Brainard GC, Dauchy RT, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of breast cancer xenografts in nude rats. Cancer Res 2005; 65: 11174-11184.
-
(2005)
Cancer Res
, vol.65
, pp. 11174-11184
-
-
Blask, D.E.1
Brainard, G.C.2
Dauchy, R.T.3
-
26
-
-
75149158379
-
Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia
-
Park S-Y, Jang W-J, Yi E-Y, et al. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia. J Pineal Res 2010; 48: 178-184.
-
(2010)
J Pineal Res
, vol.48
, pp. 178-184
-
-
Park, S.-Y.1
Jang, W.-J.2
Yi, E.-Y.3
-
27
-
-
84904500796
-
Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells
-
Proietti S, Cucina A, Dobrowolny G, et al. Melatonin down-regulates MDM2 gene expression and enhances p53 acetylation in MCF-7 cells. J Pineal Res 2014; 57: 120-129.
-
(2014)
J Pineal Res
, vol.57
, pp. 120-129
-
-
Proietti, S.1
Cucina, A.2
Dobrowolny, G.3
-
28
-
-
84872682556
-
Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin
-
Lee SE, Kim SJ, Yoon HJ, et al. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin. J Pineal Res 2013; 54: 80-88.
-
(2013)
J Pineal Res
, vol.54
, pp. 80-88
-
-
Lee, S.E.1
Kim, S.J.2
Yoon, H.J.3
-
29
-
-
33645333682
-
The role of melatonin in immuno-enhancement: Potential application in cancer
-
Miller SC, Pandi-Perumal SR, Esquifino AI, et al. The role of melatonin in immuno-enhancement: potential application in cancer. Int J Exp Pathol 2006; 87: 81-87.
-
(2006)
Int J Exp Pathol
, vol.87
, pp. 81-87
-
-
Miller, S.C.1
Pandi-Perumal, S.R.2
Esquifino, A.I.3
-
30
-
-
84879464467
-
Regulation of vascular endothelial growth factor (VEGF) by melatonin in human breast cancer cells
-
Álvarez-García V, González A, Alonso-González C, et al. Regulation of vascular endothelial growth factor (VEGF) by melatonin in human breast cancer cells. J Pineal Res 2013; 54: 373-380.
-
(2013)
J Pineal Res
, vol.54
, pp. 373-380
-
-
Álvarez-García, V.1
González, A.2
Alonso-González, C.3
-
31
-
-
77952847081
-
In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin
-
González A, Álvarez-García V, Martinez-Campa C, et al. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin. Curr Cancer Drug Targets 2010; 10: 279-286.
-
(2010)
Curr Cancer Drug Targets
, vol.10
, pp. 279-286
-
-
González, A.1
Álvarez-García, V.2
Martinez-Campa, C.3
-
32
-
-
70350646913
-
Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells
-
Martinez-Campa C, González A, Mediavilla MD, et al. Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br J Cancer 2009; 101: 1613-1619.
-
(2009)
Br J Cancer
, vol.101
, pp. 1613-1619
-
-
Martinez-Campa, C.1
González, A.2
Mediavilla, M.D.3
-
34
-
-
84858751360
-
Melatonin interferes in the desmoplastic reaction in breast cancer by cytokine production
-
Álvarez-García V, González A, Alonso-González C, et al. Melatonin interferes in the desmoplastic reaction in breast cancer by cytokine production. J Pineal Res 2012; 52: 282-290.
-
(2012)
J Pineal Res
, vol.52
, pp. 282-290
-
-
Álvarez-García, V.1
González, A.2
Alonso-González, C.3
-
35
-
-
0030025155
-
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
-
Lissoni P, Meregalli S, Nosetto L, et al. Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology 1996; 53: 43-46.
-
(1996)
Oncology
, vol.53
, pp. 43-46
-
-
Lissoni, P.1
Meregalli, S.2
Nosetto, L.3
-
36
-
-
0026303274
-
The role of DNA double strand breaks in ionizing radiation-induced killing of eucaryotic cells
-
Lliakis G,. The role of DNA double strand breaks in ionizing radiation-induced killing of eucaryotic cells. BioEssays 1991; 13: 641-648.
-
(1991)
BioEssays
, vol.13
, pp. 641-648
-
-
Lliakis, G.1
-
37
-
-
33744924482
-
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441
-
Zhao Y, Thomas HD, Batey MA, et al. Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. Cancer Res 2006; 66: 5354-5362.
-
(2006)
Cancer Res
, vol.66
, pp. 5354-5362
-
-
Zhao, Y.1
Thomas, H.D.2
Batey, M.A.3
-
38
-
-
0141757494
-
Regulation and mechanisms of mammalian double-strand break repair
-
Valerie K, Povirk LF,. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 2003; 22: 5792-5812.
-
(2003)
Oncogene
, vol.22
, pp. 5792-5812
-
-
Valerie, K.1
Povirk, L.F.2
-
39
-
-
0029762815
-
DNA repair: Enzymatic mechanisms and relevance to drug response
-
Chaney SG, Sancar A,. DNA repair: enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 1996; 88: 1346-1360.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1346-1360
-
-
Chaney, S.G.1
Sancar, A.2
-
40
-
-
0011724482
-
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients
-
Weichselbaum RR, Dahlberg W, Beckett M, et al. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci USA 1986; 83: 2684-2688.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 2684-2688
-
-
Weichselbaum, R.R.1
Dahlberg, W.2
Beckett, M.3
-
41
-
-
34249945536
-
DNA double-strand break repair: From mechanistic understanding to cancer treatment
-
Helleday T, Lo J, van Gent DC, et al. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair 2007; 6: 923-935.
-
(2007)
DNA Repair
, vol.6
, pp. 923-935
-
-
Helleday, T.1
Lo, J.2
Van Gent, D.C.3
-
42
-
-
70350504453
-
The DNA-damage response in human biology and disease
-
Jackson SP, Bartek J,. The DNA-damage response in human biology and disease. Nature 2009; 461: 1071-1078.
-
(2009)
Nature
, vol.461
, pp. 1071-1078
-
-
Jackson, S.P.1
Bartek, J.2
-
43
-
-
84878373820
-
The repair and signaling responses to DNA double-strand breaks
-
Goodarzi AA, Jeggo PA,. The repair and signaling responses to DNA double-strand breaks. Adv Genet 2013; 82: 1-45.
-
(2013)
Adv Genet
, vol.82
, pp. 1-45
-
-
Goodarzi, A.A.1
Jeggo, P.A.2
-
44
-
-
50649100744
-
Mechanism of eukaryotic homologous recombination
-
San Filippo J, Sung P, Klein H,. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem 2008; 77: 229-257.
-
(2008)
Annu Rev Biochem
, vol.77
, pp. 229-257
-
-
San Filippo, J.1
Sung, P.2
Klein, H.3
-
45
-
-
29244484430
-
Radiation and new molecular agents part 1: Targeting ATM-ATR checkpoints, DNA repair and the proteasome
-
Choudhury A, Cuddihy A, Bristow RG,. Radiation and new molecular agents part 1: targeting ATM-ATR checkpoints, DNA repair and the proteasome. Semin Radiat Oncol 2006; 16: 51-58.
-
(2006)
Semin Radiat Oncol
, vol.16
, pp. 51-58
-
-
Choudhury, A.1
Cuddihy, A.2
Bristow, R.G.3
-
46
-
-
0042632901
-
Pathways of DNA double-strand break repair during the mammalian cell cycle
-
Rothkamm K, Kruger I, Thompson LH, et al. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 2003; 23: 5706-5715.
-
(2003)
Mol Cell Biol
, vol.23
, pp. 5706-5715
-
-
Rothkamm, K.1
Kruger, I.2
Thompson, L.H.3
-
47
-
-
38049115657
-
The mechanism of human nonhomologous DNA end joining
-
Lieber MR,. The mechanism of human nonhomologous DNA end joining. J Biol Chem 2008; 283: 1-5.
-
(2008)
J Biol Chem
, vol.283
, pp. 1-5
-
-
Lieber, M.R.1
-
48
-
-
67650477223
-
DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells
-
Mao Z, Jiang Y, Liu X, et al. DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia 2009; 11: 683-691.
-
(2009)
Neoplasia
, vol.11
, pp. 683-691
-
-
Mao, Z.1
Jiang, Y.2
Liu, X.3
-
49
-
-
58549092770
-
Use of the Rad51 promoter for targeted anti-cancer therapy
-
Hine CM, Seluanov A, Gorbunova V,. Use of the Rad51 promoter for targeted anti-cancer therapy. Proc Natl Acad Sci USA 2008; 105: 20810-20815.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 20810-20815
-
-
Hine, C.M.1
Seluanov, A.2
Gorbunova, V.3
-
50
-
-
0036141394
-
Elevated levels of Rad51 recombination protein in tumor cells
-
Raderschall E, Stout K, Freier S, et al. Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res 2002; 62: 219-225.
-
(2002)
Cancer Res
, vol.62
, pp. 219-225
-
-
Raderschall, E.1
Stout, K.2
Freier, S.3
-
51
-
-
84900458715
-
DNA-PK: A dynamic enzyme in a versatile DSB repair pathway
-
Davis AJ, Chen BPC, Chen DJ,. DNA-PK: a dynamic enzyme in a versatile DSB repair pathway. DNA Repair 2014; 17: 21-29.
-
(2014)
DNA Repair
, vol.17
, pp. 21-29
-
-
Davis, A.J.1
Chen, B.P.C.2
Chen, D.J.3
-
52
-
-
0141619287
-
Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1
-
Veuger SJ, Curtin NJ, Richardson CJ, et al. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res 2003; 63: 6008-6015.
-
(2003)
Cancer Res
, vol.63
, pp. 6008-6015
-
-
Veuger, S.J.1
Curtin, N.J.2
Richardson, C.J.3
-
53
-
-
0031879187
-
Increased expression of the DNA-dependent protein kinase confers resistance to adriamycin
-
Shen H, Schultz M, Kruh GD, et al. Increased expression of the DNA-dependent protein kinase confers resistance to adriamycin. Biochim Biophys Acta 1998; 1381: 131-138.
-
(1998)
Biochim Biophys Acta
, vol.1381
, pp. 131-138
-
-
Shen, H.1
Schultz, M.2
Kruh, G.D.3
-
54
-
-
12444250680
-
DNA repair rate and etoposide (VP16) resistance of tumour cell subpopulations derived from a single human small cell lung cancer
-
Hansen LT, Lunding C, Helleday T, et al. DNA repair rate and etoposide (VP16) resistance of tumour cell subpopulations derived from a single human small cell lung cancer. Lung Cancer 2003; 40: 157-164.
-
(2003)
Lung Cancer
, vol.40
, pp. 157-164
-
-
Hansen, L.T.1
Lunding, C.2
Helleday, T.3
-
55
-
-
84871219380
-
The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells
-
Kontek R, Nowicka H,. The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells. Drug Chem Toxicol 2013; 36: 335-342.
-
(2013)
Drug Chem Toxicol
, vol.36
, pp. 335-342
-
-
Kontek, R.1
Nowicka, H.2
-
56
-
-
33644927601
-
P53 in recombination and repair
-
Gatz SA, Wiesmüller L,. p53 in recombination and repair. Cell Death Differ 2006; 13: 1003-1016.
-
(2006)
Cell Death Differ
, vol.13
, pp. 1003-1016
-
-
Gatz, S.A.1
Wiesmüller, L.2
-
57
-
-
0033580776
-
Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro
-
Mediavilla MD, Cos S, Sánchez-Barcelõ EJ,. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 1999; 65: 415-420.
-
(1999)
Life Sci
, vol.65
, pp. 415-420
-
-
Mediavilla, M.D.1
Cos, S.2
Sánchez-Barcelõ, E.J.3
-
59
-
-
33645068168
-
The human LINE-1 retrotransposon creates DNA double-strand breaks
-
Gasior SL, Wakeman TP, Xu B, et al. The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol 2006; 357: 1383-1393.
-
(2006)
J Mol Biol
, vol.357
, pp. 1383-1393
-
-
Gasior, S.L.1
Wakeman, T.P.2
Xu, B.3
-
60
-
-
84903979440
-
Regulation of L1 expression and retrotransposition by melatonin and its receptor: Implications for cancer risk associated with light exposure at night
-
Deharo D, Kines KJ, Sokolowski M, et al. Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night. Nucleic Acids Res 2014; 42: 7694-7707.
-
(2014)
Nucleic Acids Res
, vol.42
, pp. 7694-7707
-
-
Deharo, D.1
Kines, K.J.2
Sokolowski, M.3
-
61
-
-
65649135139
-
Genetic evidence that the non-homologous end-joining repair pathway is involved in LINE retrotransposition
-
Suzuki J, Yamaguchi K, Kajikawa M, et al. Genetic evidence that the non-homologous end-joining repair pathway is involved in LINE retrotransposition. PLoS Genet 2009; 5 (4): e1000461.
-
(2009)
PLoS Genet
, vol.5
, Issue.4
, pp. e1000461
-
-
Suzuki, J.1
Yamaguchi, K.2
Kajikawa, M.3
-
63
-
-
1642562820
-
Regulation of antioxidant enzymes: A significant role for melatonin
-
Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
-
(2004)
J Pineal Res
, vol.36
, pp. 1-9
-
-
Rodriguez, C.1
Mayo, J.C.2
Sainz, R.M.3
-
64
-
-
0033798633
-
Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation
-
Karbownik M, Reiter RJ,. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225: 9-22.
-
(2000)
Proc Soc Exp Biol Med
, vol.225
, pp. 9-22
-
-
Karbownik, M.1
Reiter, R.J.2
|